Recently, a growing body of evidence showed that circulating ZAG levels were significantly lower in the patients with impaired glucose tolerance (IGT) and patients with newly diagnosed type 2 diabetes mellitus (T2DM) than age and gender matched controls [2]. The gene discussed is AZGP1; the disease is diabetes mellitus.